News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Daily News Fasting Not Needed Before Cath Lab Procedures: Meta-analysis Todd Neale March 11, 2025
News Daily News Hypertension Expert George Bakris Mourned by Colleagues and Friends L.A. McKeown June 18, 2024
News Daily News No Fasting Before Cath? Study Shows No Harm—and Happier Patients L.A. McKeown January 16, 2024
News Daily News Cardiac MR Noninferior to CT for TAVI Planning, Small RCT Shows Yael L. Maxwell September 15, 2023
News Daily News ESC 2023 Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN Michael O'Riordan August 30, 2023
News Daily News PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI L.A. McKeown March 29, 2023
News Daily News NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival Caitlin E. Cox October 03, 2022
News Daily News The NCDR Has Made a Difference, but Experts See Room for Growth Todd Neale April 28, 2022
News Daily News Nonfatal MI Not a Death Surrogate in Cardiology: Meta-analysis Caitlin E. Cox October 27, 2021
News Daily News Complete Revascularization May Top Culprit-Only PCI Across ACS Types Todd Neale July 08, 2020
News Daily News CTO PCI: Lower Success, More Complications vs Other Complex PCI Yael L. Maxwell November 13, 2019
News Daily News CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL Caitlin E. Cox August 09, 2018
News Daily News Complete Revascularization for STEMI the Way to Go Even Though Evidence Isn’t Definitive: Meta-analysis Yael L. Maxwell February 15, 2018
News Daily News Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR Leah Lawrence August 10, 2017
News Daily News No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis Shelley Wood March 06, 2017
News Daily News The Good, the Bad, and the Ugly: PCI Public Reporting Needs Fine-tuning, Says SCAI Todd Neale October 20, 2016
News Daily News Semaglutide Cuts Risk of Major Cardiovascular Events in Type 2 Diabetes: SUSTAIN-6 Michael O'Riordan September 16, 2016
News Daily News Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER Michael O'Riordan June 14, 2016